CTOs on the Move

Ancient Nutrition

www.ancientnutrition.com

 
At Ancient Nutrition, our mission is to restore our health, strength and vitality by providing history`s healthiest whole food nutrients to the modern world.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Ancient Nutrition raised $103M on 03/08/2018

Similar Companies

Diamond Herpanacine Assoc

Diamond Herpanacine Assoc is a Glenside, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lets Talk Spech Language Svcs

Lets Talk Spech Language Svcs is a Raleigh, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Clarvista Medical

ClarVista Medical` based in Aliso Viejo` California is a leading developer of innovative products to treat challenging ophthalmic conditions. In 2012 and in conjunction with series A financing` ClarVista was spun out from Prospex Medical` a medical device incubator` to pursue the development of the HARMONI™ IOL. Between 2012 and 2014` the company developed the first generation HARMONI™ system` conducted thorough first-in-human clinical study and developed a broad portfolio of intellectual property. In 2015 the company closed on a series B financing of $14M which will be used to develop the second generation HAROMONI™ system` conduct a larger feasibility clinical trial and obtain key regulatory approvals including CE mark and US IDE.

SolutionHealth

SolutionHealth is a new, regional healthcare system comprised of Elliot Health System and Southern New Hampshire Health. SolutionHealth allows both Elliot Health System and Southern New Hampshire Health to be even better together by pursuing actionable strategies to improve the health of our communities with collaborations that improve access to high quality, high value care delivered locally.

Metamark

Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.